Restor3d raises $38M to support 3D-printed product lines
Summary
This positions it to continue reinvesting in innovation and expansion while maintaining financial stability.The new product lines set to be supported by the new funds include the Veritas, iTotal Identity, Kinos and Velora implant offerings. The FDA-cleared iTotal Identity delivers optimal coverage and precise alignment while eliminating intraoperative guesswork. Kinos, a total ankle system delivered through an anterior approach, also has FDA clearance.Finally, Velora, a next-generation 3DP porous acetabular system, promotes osseointegration by incorporating Tidal technology and long-term stability in hip arthroplasty procedures. That system also awaits FDA 510(k) clearance.By leveraging advanced 3D printing and AI-driven design, we are restoring mobility and improving liveswhether its helping patients return to work, get back on the golf course, or simply walk without pain, said Kurt Jacobus, CEO and co-founder. This funding allows us to further scale our technology, expand access to truly personalized care, and continue setting new standards in orthopedic treatment.